MercadoLibre, Inc. (MELI) › Analysis

MercadoLibre (MELI) stock analysis, November 3, 2026: Downtrend intact into earnings, sellers waiting near $1,700

Published November 3, 2026 · updated 2026-11-06 · MELI chart, levels and live analysis

Update, November 6, 2026

MercadoLibre (MELI) fell 7.1% over the past five sessions to $1,510.00, underperforming the S&P 500's 2.7% decline and the Consumer Cyclical sector's 1.9% gain, as the market digested its mixed Q3 earnings. Revenue of $10.75 billion beat estimates, but EPS of $8.83 missed, and operating margins contracted to 6.3% from 12.2% a year earlier, pressuring shares (Benzinga). The stock also slipped 1.3% on Friday after Reuters reported that Mercado Pago halted some crypto transfers due to an external provider disruption.

The picture holds. The weekly downtrend remains intact, with price below its 40-week average and lagging the S&P 500 by 13.0% over 50 days. The stock is now testing the $1,500 round support, with a daily close below that level opening a downside breakout toward $1,450, though the reward-to-risk is only 0.7. Resistance at $1,550 (round) and $1,568.38 (swing zone) has moved closer, while $1,661.34 remains the level that would change the picture on a weekly close above. The prior invalidation at $1,765.48 is now distant. RSI at 26.2 is deeply oversold, and volume is 30% above average, suggesting continued selling pressure.

MercadoLibre (MELI) trades at $1,670.93, 11.7% below its October 12, 2026 closing peak, and goes into earnings on November 4 beneath both its 50-day and 200-day averages. No company news explains the slide. The stock has lagged the market and its sector while the weekly downtrend ran on. The balance of evidence for the next two to six weeks leans negative, with high conviction, even though the shares are oversold and analysts sit far above the price.

Why it matters

There is no single event behind the drop from $1,892.44 on October 12. The company-specific flow was commentary, not news: head-to-head comparison pieces and a note that Ark Invest bought MercadoLibre during the recent weakness. The closest thing to a cause is the technology sell-off that The Motley Fool tied to rising interest rates and AI spending costs. That explains pressure on expensive growth names in general. It does not explain why MELI has been weaker than its peers. The decline has also been quiet: volume today is about 59% below its 20-day average, so this is steady selling, not a panic that has already cleared the sellers out.

The last five days show whose move it was. The S&P 500 fell 2.1% and the consumer discretionary sector fund XLY rose 1.5%. MELI slipped 0.6%, which is better than the market but 2.1 points behind its sector. Over 50 days the gap is wider: 7.1 points behind the S&P 500 and 11.8 behind XLY. The market is not what is holding MELI down. The stock itself is the weak link, and buyers have not shown up on the days the sector rose.

The debate is about what growth is worth when profit is shrinking. The bulls point to the numbers: Yahoo! Finance cites first-half 2026 revenue of $19 billion, up 49%, and argues MELI is a cheaper way into growth than the largest US technology names. The Motley Fool notes the stock is 37% below its record high despite revenue growth near 50%. The cautious side points to the same report from the other end: net income fell 13% to $883 million on margin cuts and higher bad-loan costs. A Yahoo! Finance piece on cross-platform users concedes the structural advantage but notes the shares have still fallen 14.4% in three months. Both sides agree the business is growing, and the market is pricing the lower profit.

Valuation shows how far apart the stock and the analysts are. The 26 analysts rate it a strong buy, with a mean price target of $2,271.93, which puts the price 26.5% below it. Even the lowest target, $1,750, is above the current price, and the highest is $2,800. Targets that high above a falling stock usually lag the price rather than lead it. They show how much the earnings report has to deliver for the gap to close from the analysts' side.

What the evidence says

On the long term, the thesis is weakened but not broken. The stock is below its 10-week and 40-week averages and sits 27.9% under its 52-week high of $2,316.40. It is down 9.7% over six months and 17.0% for the year, yet only 8% above its 52-week low of $1,546.81. The business is still growing quickly, but profit has slipped and the market has cut the multiple it will pay. This looks like a markdown phase in a larger downtrend, not yet a capitulation. The 50-day average at $1,830.17 now sits above the 200-day at $1,809.19, and the price is below both.

For the next two to six weeks the balance of evidence leans negative, and conviction is high at 3 of 4. The daily trend runs with the weekly downtrend, and MELI trails both the S&P 500 and XLY over 50 days. Those three points all lean the same way.

The strongest case against is the bounce case. RSI is 30.12, which is oversold, and the shares are 11.7% off their peak on light volume. Ark has been buying, a recent upgrade has been reported, and earnings come tomorrow. A good report could force a sharp squeeze, and the average daily range of about $64 means a gap could carry the price through several levels at once. That does not tip the balance. An oversold reading shows how stretched the move is, not that the trend has turned, and the first stretch of any bounce runs into sellers near $1,700. The earnings event is a large part of why the fourth conviction point is missing.

Levels that matter

The structure holds below $1,700, a round number where sellers have shown up on earlier rallies. Above it sit $1,735.89 and $1,750, and the weekly downtrend ends only above $1,765.48, a swing zone. Until the price clears that level, rallies are moves inside the downtrend. The 200-day average at $1,809.19 is the next marker above.

The breakout level is a daily close below $1,661.34, only about $10 under the current price. From there the first target is $1,560.92, a swing zone, at 1.8 to 1. The second is the 52-week low at $1,546.81, at 2.1 to 1. The breakdown would be wrong above $1,716.12, which is $1,700 plus a quarter of the average daily range. The math does not reach 3 to 1. It would take a downside target below the 52-week low, and no mapped level sits there. Support at $1,650 and $1,600 lies on the way down and could slow the move.

What would change the picture

A weekly close above $1,765.48 would be the first sign that buyers are back and the downtrend has ended. A close above the price alone would be incomplete. The fact that would make it last is profit growing again alongside revenue. If net income stops shrinking and loan losses stay contained, the main argument against the stock loses its footing, and the gap to the analyst targets starts to look like opportunity rather than a warning.

What to watch

Get a message when the MELI picture changes — the agent team watches the levels and the news for you.Create a free account

More MELI analyses

Research & education, not advice. MarketCrew is AI-powered and can make mistakes.